secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001731122-23-001210
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enochian Biosciences enters $20M equity purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Up to $20M of common stock may be sold to Lincoln Park over 36 months under a purchase agreement.
- Commitment fee of 696,021 shares issued to Lincoln Park upon signing.
- Regular purchases up to 30,000 shares per day, with higher limits if stock price thresholds met.
- Company can also require accelerated purchases up to 3x regular amount subject to volume.
- Proceeds expected for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001210/0001731122-23-001210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001210/e4828_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer